Back to search

Article

Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host

2024-05-06

Abstract excerpt

<h4>Summary</h4> Glioblastoma (GBM) is the most common primary brain tumor in adults with a poor prognosis despite aggressive therapy. A recent, retrospective clinical study found that administering Temozolomide in the morning increased patient overall survival by 6 months compared to evening. Here, we tested the hypothesis that daily host signaling regulates tumor growth and synchronizes circadian rhythms in GBM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b158e8a-8431-5f3a-ba63-acdc65faa740
DOI
10.1101/2024.05.03.592418
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the hostDOI 10.1101/2024.05.03.592418
Select a neighboring publication to make it the new centre.